Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Viridian Therapeutics, Inc.
13G/A
Amendment 2
VRDN · 92790C104
|
5.7% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 5.7% | ||||
| Kynam Capital Management GP, LLC | 5.7% | ||||
| Yue Tang | 5.7% | ||||
|
Vera Therapeutics, Inc.
13G/A
Amendment 1
VERA · 92337R101
|
4.0% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 4.0% | ||||
| Kynam Capital Management GP, LLC | 4.0% | ||||
| Yue Tang | 4.0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 2
CTMX · 23284F105
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 10.0% | ||||
| Kynam Capital Management GP, LLC | 10.0% | ||||
| Yue Tang | 10.0% | ||||
|
Celldex Therapeutics, Inc.
13G/A
Amendment 4
CLDX · 15117B202
|
6.8% |
8/14/2026
Event 6/30/2026
|
|||
| Kynam Capital Management, LP | 6.8% | ||||
| Kynam Capital Management GP, LLC | 6.8% | ||||
| Yue Tang | 6.8% | ||||
|
Burning Rock Biotech Ltd
13G/A
Amendment 4
BNR · 12233L107
|
14.0% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 14.0% | ||||
| Kynam Capital Management GP, LLC | 14.0% | ||||
| Yue Tang | 14.0% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 1
CTMX · 23284F105
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 6.9% | ||||
| Kynam Capital Management GP, LLC | 6.9% | ||||
| Yue Tang | 6.9% | ||||
|
Celldex Therapeutics, Inc.
13G/A
Amendment 3
CLDX · 15117B202
|
8.8% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 8.8% | ||||
| Kynam Capital Management GP, LLC | 8.8% | ||||
| Yue Tang | 8.8% | ||||
|
Sutro Biopharma, Inc.
13G/A
Amendment 1
STRO · 869367102
|
5.3% |
5/15/2026
Event 3/31/2026
|
|||
| Kynam Capital Management, LP | 5.3% | ||||
| Kynam Capital Management GP, LLC | 5.3% | ||||
| Yue Tang | 5.3% | ||||
|
CytomX Therapeutics, Inc.
13G
CTMX · 23284F105
|
5.3% |
3/4/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 5.3% | ||||
| Kynam Capital Management GP, LLC | 5.3% | ||||
| Yue Tang | 5.3% | ||||
|
Cullinan Therapeutics, Inc.
13G
CGEM · 230031106
|
5.3% |
3/4/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 5.3% | ||||
| Kynam Capital Management GP, LLC | 5.3% | ||||
| Yue Tang | 5.3% | ||||
|
Viridian Therapeutics, Inc.
13G/A
Amendment 1
VRDN · 92790C104
|
1.5% |
2/17/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 1.5% | ||||
| Kynam Capital Management GP, LLC | 1.5% | ||||
| Yue Tang | 1.5% | ||||
|
enGene Holdings Inc.
13G/A
Amendment 1
ENGN · 29286M105
|
2.2% |
2/17/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 2.2% | ||||
| Kynam Capital Management GP, LLC | 2.2% | ||||
| Yue Tang | 2.2% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 2
COGT · 19240Q201
|
4.3% |
2/17/2026
Event 12/31/2025
|
|||
| Kynam Capital Management, LP | 4.3% | ||||
| Kynam Capital Management GP, LLC | 4.3% | ||||
| Yue Tang | 4.3% | ||||
|
Burning Rock Biotech Ltd
13G/A
Amendment 3
BNR · 12233L107
|
11.0% |
11/14/2025
Event 9/30/2025
|
|||
| Kynam Capital Management, LP | 11.0% | ||||
| Kynam Capital Management GP, LLC | 11.0% | ||||
| Yue Tang | 11.0% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 1
COGT · 19240Q201
|
5.5% |
11/14/2025
Event 9/30/2025
|
|||
| Kynam Capital Management, LP | 5.5% | ||||
| Kynam Capital Management GP, LLC | 5.5% | ||||
| Yue Tang | 5.5% | ||||
|
Vera Therapeutics, Inc.
13G
VERA · 92337R101
|
5.4% |
8/14/2025
Event 6/30/2025
|
|||
| Kynam Capital Management, LP | 5.4% | ||||
| Kynam Capital Management GP, LLC | 5.4% | ||||
| Yue Tang | 5.4% | ||||
|
Celldex Therapeutics, Inc.
13G/A
Amendment 2
CLDX · 15117B202
|
9.8% |
5/15/2025
Event 3/31/2025
|
|||
| Kynam Capital Management, LP | 9.8% | ||||
| Kynam Capital Management GP, LLC | 9.8% | ||||
| Yue Tang | 9.8% | ||||
|
Viridian Therapeutics, Inc.
13G
VRDN · 92790C104
|
5.8% |
5/15/2025
Event 3/31/2025
|
|||
| Kynam Capital Management, LP | 5.8% | ||||
| Kynam Capital Management GP, LLC | 5.8% | ||||
| Yue Tang | 5.8% | ||||
|
Sutro Biopharma, Inc.
13G
STRO · 869367102
|
6.4% |
5/15/2025
Event 3/31/2025
|
|||
| Kynam Capital Management, LP | 6.4% | ||||
| Kynam Capital Management GP, LLC | 6.4% | ||||
| Yue Tang | 6.4% | ||||
|
2seventy Bio, Inc.
13G/A
Amendment 1
TSVT · 901384107
|
0% |
3/17/2025
Event 3/11/2025
|
|||
| Kynam Capital Management, LP | 0% | ||||
| Kynam Capital Management GP, LLC | 0% | ||||
| Yue Tang | 0% | ||||
| Kynam Global Healthcare Master Fund, LP | 0% | ||||
| Kynam Fund GP, LLC | 0% | ||||
|
Syndax Pharmaceuticals Inc
13G/A
Amendment 1
SNDX · 87164F105
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 10.0% | ||||
| Kynam Capital Management GP, LLC | 10.0% | ||||
| Yue Tang | 10.0% | ||||
|
enGene Holdings Inc.
13G
ENGN · 29286M105
|
9.8% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 9.8% | ||||
| Kynam Capital Management GP, LLC | 9.8% | ||||
| Yue Tang | 9.8% | ||||
|
Dynavax Technologies Corp
13G/A
Amendment 1
DVAX · 268158201
|
4.99% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 4.99% | ||||
| Kynam Capital Management GP, LLC | 4.99% | ||||
| Yue Tang | 4.99% | ||||
|
Celldex Therapeutics, Inc.
13G/A
Amendment 1
CLDX · 15117B202
|
7.6% |
2/14/2025
Event 12/31/2024
|
|||
| Kynam Capital Management, LP | 7.6% | ||||
| Kynam Capital Management GP, LLC | 7.6% | ||||
| Yue Tang | 7.6% | ||||